Biotechnology Stocks I Performance Guide: Compare Returns of S&P 500 and Neumora Therapeutics, Inc. (NMRA)
Values are based on monthly closes adjusted for splits and dividends from Alpha Vantage.
Compare Returns for S&P 500 and NMRA | ||
---|---|---|
S&P 500 | NMRA | |
Start Date | Oct-02-2023 | Oct-31-2023 |
Start Price | $2,476.46 | $10.92 |
End Date | May-01-2024 | May-17-2024 |
End Price | $5,018.39 | $9.67 |
Number Monthly Prices | 8 | 8 |
Min Date | Oct-02-2023 | Apr-30-2024 |
Min Price | $4,326.11 | $9.09 |
Max Date | Apr-01-2024 | Feb-29-2024 |
Max Price | $5,243.77 | $17.63 |
Total Return | 16.00% | -11.45% |
Annualized Return | 24.94% | -16.67% |
Current Value of $1,000 Purchase | $1,160 | $886 |
Number Returns | 28 | 28 |
Average Return | 7.81% | -4.31% |
Minimum Return | -4.30% | -48.44% |
Maximum Return | 21.21% | 61.45% |
Number Profitable Returns | 25 | 12 |
Percent Profitable Returns | 89.29% | 42.86% |
Number Unprofitable Returns | 3 | 16 |
Percent Unprofitable Returns | 10.71% | 57.14% |
Profitable to Unprofitable Returns Ratio | 8.33 | 0.75 |
NMRA Performance Table and Chart
NMRA Dollar-cost Average
NMRA Trendline Chart
NMRA Moving Average Chart
NMRA Stock Return Map - See Patterns of Gains and Losses
NMRA Stock Returns/Purchase Dates